CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verbessem, D.
Right arrow Articles by Van de Velde, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verbessem, D.
Right arrow Articles by Van de Velde, A.

Canadian Journal of Anesthesia, Vol 40, 4-9, Copyright © 1993 by Canadian Anesthesiologists' Society

ARTICLES

Does ranitidine provide protection against acid gastroesophageal reflux?

D Verbessem, F Camu and A Van de Velde
Department of Anaesthesiology, Flemish Free University of Brussels Medical Center, Belgium.

Continuous gastroesophageal pH monitoring was used to evaluate the effect of ranitidine on gastroesophageal reflux (GOR) in 60 patients scheduled for elective non-gastrointestinal abdominal or gynaecological surgery. The patients were randomly assigned to receive a single dose of ranitidine 50 mg either iv (RANIV group) or im (RANIM group) or a placebo iv (PLAC group) 90 min before surgery. The pH was measured continuously for six hours in the lower oesophagus using a flexible calibrated glass electrode. A pH < 4.0 was chosen as the boundary for defining occurrence of acid GOR. Both ranitidine treatments reduced the total number of acid reflux episodes and the global reflux index (P < 0.05). The duration of the acid reflux episodes (sum of refluxes) and the number of acid reflux episodes longer than five minutes were markedly decreased by ranitidine but the mean duration of the reflux episodes was unaffected. The pH values at induction, intubation, surgical incision and extubation were similar in the PLAC and RANIV groups but more acid than in the RANIM group. The mean pH of reflux episodes was less acid in both ranitidine groups than in the PLAC group (P < 0.05). Also the number of very acid refluxes (pH < 2.5) decreased with ranitidine (P < 0.05). Intramuscular and intravenous administration of ranitidine provide protection against gastroesophageal reflux, with shorter duration of reflux episodes occurring in the intramuscular group. Regardless of the administration of ranitidine, protection against gastroesophageal reflux is incomplete; the frequency of reflux episodes is reduced but not eliminated.


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
S. Darshane, P. Groom, and P. Charters
Responsive Contingency Planning: a novel system for anticipated difficulty in airway management in dental abscess
Br. J. Anaesth., December 1, 2007; 99(6): 898 - 905.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
N. M. Agnew, J. B. Kendall, M. Akrofi, J. Tran, A. S. Soorae, R. Page, G. N. Russell, and S. H. Pennefather
Gastroesophageal Reflux and Tracheal Aspiration in the Thoracotomy Position: Should Ranitidine Premedication be Routine?
Anesth. Analg., December 1, 2002; 95(6): 1645 - 1649.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Canadian Anesthesiologists' Society.